ISCT 2023, Paris

ISCT 2023, Paris - Corporate News

We are pleased to announce the presence of our CSO, Nicolas Grandchamp, PhD at the ISCT congress in Paris, from May 31 to June 3.

GEG-Tech Signs Distribution Agreement with Tebu-Bio


GEG-tech’s agreement with tebu-bio expands the distribution of advanced vectorisation systems & tools, designed by GEG-tech (genetic engineering lab) into the European Market. GEG-tech, the technology leader in advanced lentiviral vectorisation systems, announces a distribution agreement with tebu-bio to bolster its coverage of the European Market. tebu-bio, is a pan-european distributor of speciality real agents […]

Innovation in cancerology: meeting in Monaco


GEG Tech will be attending the 14th Biennale Monegasque de Cancerologie. It will take place at the end on Januray 2020 in Monaco. More than 1300 participants will be gathering and discussing the evolution and progresses of cancerology. Various themes will be discussed, among them last innovations and new molecules, news in hematology, access to […]

Gene therapy: An Extensive Overview


Recent advances in the field of genetic engineering are expanding the capability of gene therapy to treat diseases, notably those previously unreachable. As a proof, the last two years saw the number of marketing authorization for gene therapy products significantly rise. Last month, Novartis has obtained Canadian approvement for its CAR-T Therapy, Kymriah. For its […]

CAR-Based Immunotherapy

CAR-Based Immunotherapy - Corporate News

We would like to share some exciting results on CAR-Based Immunotherapy. It comes from our partner Dr Oana Gavriliuc from OncoGen “Victor Babes” University of Medicine and Pharmacy, Timisoara (Romania). We are proud to introduce the poster presented by Dr Gavriliuc at the ICLE 2019 (London). The poster titled CAR-Based Immunotherapy of EGFR positive solid tumors using […]

ANCHOR Technology / Partnership

GFP spots in living cells

We are proud to annonce you that GEG Tech has validated the combination of the ANCHOR technology developed by NeoVirTech with our Lenti-ONE vectors. This  breakthrough technology allowed us to generate the first auto-fluorescent lentiviral vectors for live imaging and screening applications. For more details about the new possibilities offered by the ANCHOR Lenti-ONE, please take a look here. And […]

Preclinical and Personalized Breast Cancer Research

Preclinical and Personalized Breast Cancer Research - Corporate News

As scientists involved in life science research, we would like to let you know about the research project on breast cancer, led by the Brisken Lab in EPFL, Switzerland. The scientific team of GEG Tech is proud to be a part of it, designing advanced vectorization systems required by this promising research. Please find a […]